ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 232 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,112,287 | -25.6% | 149,342 | -14.5% | 0.00% | -25.0% |
| Q2 2023 | $4,183,202 | +8.5% | 174,664 | -14.7% | 0.00% | 0.0% |
| Q1 2023 | $3,854,562 | +20.7% | 204,812 | +2.1% | 0.00% | +33.3% |
| Q4 2022 | $3,194,826 | +10.0% | 200,680 | +13.0% | 0.00% | 0.0% |
| Q3 2022 | $2,905,000 | +9.3% | 177,569 | -5.9% | 0.00% | 0.0% |
| Q2 2022 | $2,659,000 | -35.6% | 188,737 | +10.7% | 0.00% | -25.0% |
| Q1 2022 | $4,130,000 | +0.1% | 170,562 | -3.5% | 0.00% | +100.0% |
| Q4 2021 | $4,124,000 | +2.8% | 176,661 | -26.9% | 0.00% | 0.0% |
| Q3 2021 | $4,013,000 | +29.3% | 241,594 | +89.9% | 0.00% | 0.0% |
| Q2 2021 | $3,104,000 | -17.9% | 127,254 | -13.2% | 0.00% | 0.0% |
| Q1 2021 | $3,783,000 | -52.2% | 146,630 | -1.0% | 0.00% | -50.0% |
| Q4 2020 | $7,918,000 | +37.1% | 148,119 | +5.8% | 0.00% | 0.0% |
| Q3 2020 | $5,776,000 | -60.1% | 140,028 | -53.2% | 0.00% | -60.0% |
| Q2 2020 | $14,494,000 | +226.4% | 299,053 | +184.6% | 0.01% | +150.0% |
| Q1 2020 | $4,441,000 | -46.1% | 105,095 | -45.4% | 0.00% | -33.3% |
| Q4 2019 | $8,234,000 | -0.5% | 192,506 | -16.3% | 0.01% | -14.3% |
| Q3 2019 | $8,275,000 | +182.5% | 229,943 | +109.9% | 0.01% | +133.3% |
| Q2 2019 | $2,929,000 | +21.7% | 109,568 | +22.2% | 0.00% | +50.0% |
| Q1 2019 | $2,406,000 | +62.0% | 89,630 | -2.4% | 0.00% | 0.0% |
| Q4 2018 | $1,485,000 | -4.8% | 91,866 | +22.2% | 0.00% | +100.0% |
| Q3 2018 | $1,560,000 | +1.0% | 75,199 | -25.7% | 0.00% | -50.0% |
| Q2 2018 | $1,545,000 | -15.4% | 101,195 | +24.5% | 0.00% | 0.0% |
| Q1 2018 | $1,826,000 | -27.4% | 81,285 | -2.6% | 0.00% | 0.0% |
| Q4 2017 | $2,515,000 | -70.3% | 83,485 | -62.9% | 0.00% | -75.0% |
| Q3 2017 | $8,474,000 | +13.6% | 224,985 | -15.9% | 0.01% | +14.3% |
| Q2 2017 | $7,458,000 | -36.5% | 267,380 | -21.8% | 0.01% | -36.4% |
| Q1 2017 | $11,749,000 | +89.8% | 341,746 | +59.2% | 0.01% | +83.3% |
| Q4 2016 | $6,189,000 | +102.3% | 214,621 | +123.3% | 0.01% | +100.0% |
| Q3 2016 | $3,059,000 | -48.4% | 96,125 | -47.3% | 0.00% | -57.1% |
| Q2 2016 | $5,926,000 | +46.2% | 182,537 | +25.9% | 0.01% | +40.0% |
| Q1 2016 | $4,053,000 | +48.5% | 144,938 | +89.4% | 0.01% | +66.7% |
| Q4 2015 | $2,729,000 | +25.8% | 76,530 | +16.6% | 0.00% | 0.0% |
| Q3 2015 | $2,170,000 | -69.3% | 65,610 | -61.2% | 0.00% | -57.1% |
| Q2 2015 | $7,073,000 | +140.8% | 168,892 | +87.4% | 0.01% | +133.3% |
| Q1 2015 | $2,937,000 | -6.1% | 90,115 | -8.5% | 0.00% | 0.0% |
| Q4 2014 | $3,127,000 | -64.6% | 98,489 | -72.4% | 0.00% | -57.1% |
| Q3 2014 | $8,829,000 | -56.7% | 356,629 | -60.5% | 0.01% | -58.8% |
| Q2 2014 | $20,379,000 | -39.5% | 902,150 | -34.8% | 0.02% | -48.5% |
| Q1 2014 | $33,688,000 | +17.5% | 1,384,614 | +20.7% | 0.03% | +26.9% |
| Q4 2013 | $28,659,000 | +1091.1% | 1,146,913 | +1209.9% | 0.03% | +1200.0% |
| Q3 2013 | $2,406,000 | +8.4% | 87,554 | -28.4% | 0.00% | 0.0% |
| Q2 2013 | $2,219,000 | +157.4% | 122,300 | +12.7% | 0.00% | +100.0% |
| Q1 2013 | $862,000 | – | 108,561 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |